Appia Bio

Appia Bio is a preclinical-stage biotechnology company headquartered in Los Angeles, California, dedicated to developing revolutionary allogeneic cell therapies for cancer patients. Their innovative approach focuses on harnessing the unique properties of invariant natural killer T (iNKT) cells and gamma delta T cells, leveraging these innate-like T cells for their potent cancer-fighting abilities. Appia Bio's proprietary ACUA technology platform enables the generation of CAR-engineered iNKT and gamma delta T cells from hematopoietic stem cells (HSCs), offering a scalable and off-the-shelf treatment option with the potential to improve efficacy and access for patients.

Their commitment to innovation is evident in their partnerships with leading institutions and companies in the cell therapy field, including Kite (a Gilead Company), and their ongoing research and development efforts. Appia Bio's vision is to create novel, curative, and accessible cell therapies, ultimately transforming the lives of cancer patients and shaping the future of cancer treatment.

Appia Bio is a biotechnology company dedicated to developing next-generation, off-the-shelf allogeneic cell therapies for cancer patients. Their mission is to create novel, curative, and accessible treatments through their proprietary ACUA technology platform, which leverages the biology of lymphocyte development to generate CAR-engineered invariant natural killer T (CAR-iNKT) cells from hematopoietic stem cells (HSCs). This allows for scalable production of cell therapies that can be readily available to patients, ultimately transforming cancer treatment and improving outcomes for those battling the disease.

Appia Bio fosters a culture of collaborative innovation and excellence, emphasizing teamwork, perseverance, and a shared commitment to transforming cancer treatment. They encourage open communication, transparency, and a sense of community, valuing diversity of thought and experience while maintaining the highest standards of integrity and scientific rigor. Their leadership team is accessible and actively involved, reflecting a supportive environment that empowers employees to make a real impact in the field of cell therapy.

Appia Bio explicitly promotes a culture of diversity, equity, and inclusion, stating their commitment to creating a community comprised of diverse perspectives, functions, and backgrounds united by their common mission. This commitment is reflected in their values, which emphasize integrity, excellence, teamwork, perseverance, and unity. Appia Bio's emphasis on fostering a welcoming and inclusive environment for employees is evident in their communication and branding, promoting a culture of open dialogue and collaboration, and highlighting the importance of individual contributions.